Author:
Krishnan Usha S,Rosenzweig Erika Berman
Reference129 articles.
1. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE et al (2010) Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest 137(2):376–387
2. Fraisse A, Jaïs X, Schleich J-M, Filippo SD, Maragnès P, Beghetti M et al (2010) Characteristics and prospective two-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis Suppl 2(2):137–145
3. Van Loon RLE, Roofthooft MTR, Hillege HL, Ten Harkel ADJ, Van Osch-Gevers M, Delhaas T et al (2011) Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation 124(16):1755–1764
4. D’Alonzo GE, Barst RJ, Ayres SM et al (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115(5):343–349. https://doi.org/10.7326/0003-4819-115-5-
5. McLaughlin VV, Shillington A, Rich S (2002) Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 106(12):1477–1482